Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Mar 2024 14:30

RNS Number : 8693F
Indivior PLC
06 March 2024
 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that on March 5, 2024, Mark Crossley, Chief Executive Officer and a PDMR, received 91,204 ordinary shares in the Company of $0.50 each ('Shares').

This arose as a result of the release of awards granted on March 5, 2019 and August 8, 2019 under the Indivior Long-Term Incentive Plan, which vested in respect of a total of 159,311 Shares on March 5, 2021 and which were then subject to a two-year post-vesting holding period. Following the end of the holding period, the Shares were released on March 5, 2024 on a net settled basis, resulting in the delivery of 91,204 Shares.

Following this transaction, Mark Crossley has a beneficial interest in 181,236 Shares in the Company.

This notification is made in accordance with the requirements of the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Mark Crossley

2

 

Reason for the notification

 

a)

 

Position/status

  

Director / PDMR - Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Indivior PLC

b)

 

LEI

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Release of Shares following the end of the two-year holding period after vesting of an award granted under the Indivior Long-Term Incentive Plan.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

N/A

91,204

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 5, 2024

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUPGWUPCGCQ
Date   Source Headline
4th Feb 20197:00 amRNSIndivior to Divest Interest in China
1st Feb 20193:00 pmRNSTotal Voting Rights
25th Jan 20197:00 amRNSIndivior Granted Temporary Restraining Order
24th Jan 20199:28 amRNSHolding(s) in Company
22nd Jan 20193:51 pmRNSHolding(s) in Company
21st Jan 20197:00 amRNSNotice of Results
9th Jan 20193:07 pmRNSHolding(s) in Company
3rd Jan 20198:44 amRNSHolding(s) in Company
20th Dec 20187:00 amRNSIndivior publishes real-world RECOVER study design
18th Dec 201812:00 pmRNSIndivior Trading Update
13th Dec 20182:41 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSFederal Court Declines Immediate Issue of Mandate
30th Nov 20182:45 pmRNSIndivior Prepays Debt
29th Nov 20187:00 amRNSHolding(s) in Company
28th Nov 20182:39 pmRNSHolding(s) in Company
27th Nov 20187:00 amRNSIndivior Announces Update Call
23rd Nov 20187:00 amRNSHealth Canada Approves SUBLOCADE(TM)
21st Nov 20184:20 pmRNSHolding(s) in Company
21st Nov 201811:57 amRNSHolding(s) in Company
21st Nov 20187:00 amRNSIndivior Responds to Federal Court Decision
20th Nov 20184:40 pmRNSSecond Price Monitoring Extn
20th Nov 20184:35 pmRNSPrice Monitoring Extension
20th Nov 20183:28 pmRNSINDIVIOR MAKES STATEMENT ON COURT DECISION
19th Nov 20184:00 pmRNSDirectorate Change
19th Nov 20181:02 pmRNSPERSERIS(TM) Availability
16th Nov 20183:52 pmRNSDirector Declaration
13th Nov 20184:22 pmRNSHolding(s) in Company
9th Nov 20183:00 pmRNSBlock listing Interim Review
6th Nov 20182:37 pmRNSHolding(s) in Company
6th Nov 20187:00 amRNSIndivior Announces Upcoming Investor Events
1st Nov 20187:00 amRNSTotal Voting Rights
31st Oct 20181:12 pmRNSHolding(s) in Company
30th Oct 20188:53 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSIndivior Applauds New U.S. Opioid Legislation
23rd Oct 20183:55 pmRNSHolding(s) in Company
17th Oct 20187:00 amRNSNotice of Results
5th Oct 20184:04 pmRNSHolding(s) in Company
28th Sep 20184:29 pmRNSHolding(s) in Company
26th Sep 20184:41 pmRNSSecond Price Monitoring Extn
26th Sep 20184:35 pmRNSPrice Monitoring Extension
26th Sep 20184:19 pmRNSIndivior Provides Business Update
20th Sep 20183:50 pmRNSHolding(s) in Company
19th Sep 20183:35 pmRNSDirector Declaration
12th Sep 20187:00 amRNSIndivior unable to attend Investor Conference
10th Sep 20187:00 amRNSIndivior Prepays $150 Million of Outstanding Debt
4th Sep 20187:00 amRNSMorgan Stanley Annual Global Healthcare Conference
21st Aug 20184:37 pmRNSHolding(s) in Company
10th Aug 20183:38 pmRNSHolding(s) in Company
6th Aug 20184:19 pmRNSHolding(s) in Company
1st Aug 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.